MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR

The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Acti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAN, YUING EUGENE, GATELY, MAURICE KENT, HULMES, JEFFREY DAVID W, STERN, ALVIN SETH, CHIZZONITE, RICHARD ANTHONY, GUBLER, ULRICH ANDREAS, PODLANSKI, FRANK JOHN
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAN, YUING EUGENE
GATELY, MAURICE KENT
HULMES, JEFFREY DAVID W
STERN, ALVIN SETH
CHIZZONITE, RICHARD ANTHONY
GUBLER, ULRICH ANDREAS
PODLANSKI, FRANK JOHN
description The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE369383TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE369383TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE369383TT13</originalsourceid><addsrcrecordid>eNrjZAj09ffz9_bx93P0cVVw9Avx9D48LSjANUghOMA1ytPNM9jZQ8Ht8JwgBRdXP4WoyBD_EP8IkCCQ5xPpG-DhDxRz9dMNcvV0c3Vz9A7xD-JhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGOIa7GZpbGFsYhIYbGxKgBAAz7MoU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR</title><source>esp@cenet</source><creator>PAN, YUING EUGENE ; GATELY, MAURICE KENT ; HULMES, JEFFREY DAVID W ; STERN, ALVIN SETH ; CHIZZONITE, RICHARD ANTHONY ; GUBLER, ULRICH ANDREAS ; PODLANSKI, FRANK JOHN</creator><creatorcontrib>PAN, YUING EUGENE ; GATELY, MAURICE KENT ; HULMES, JEFFREY DAVID W ; STERN, ALVIN SETH ; CHIZZONITE, RICHARD ANTHONY ; GUBLER, ULRICH ANDREAS ; PODLANSKI, FRANK JOHN</creatorcontrib><description>The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.</description><language>ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070815&amp;DB=EPODOC&amp;CC=AT&amp;NR=E369383T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070815&amp;DB=EPODOC&amp;CC=AT&amp;NR=E369383T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAN, YUING EUGENE</creatorcontrib><creatorcontrib>GATELY, MAURICE KENT</creatorcontrib><creatorcontrib>HULMES, JEFFREY DAVID W</creatorcontrib><creatorcontrib>STERN, ALVIN SETH</creatorcontrib><creatorcontrib>CHIZZONITE, RICHARD ANTHONY</creatorcontrib><creatorcontrib>GUBLER, ULRICH ANDREAS</creatorcontrib><creatorcontrib>PODLANSKI, FRANK JOHN</creatorcontrib><title>MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR</title><description>The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAj09ffz9_bx93P0cVVw9Avx9D48LSjANUghOMA1ytPNM9jZQ8Ht8JwgBRdXP4WoyBD_EP8IkCCQ5xPpG-DhDxRz9dMNcvV0c3Vz9A7xD-JhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGOIa7GZpbGFsYhIYbGxKgBAAz7MoU</recordid><startdate>20070815</startdate><enddate>20070815</enddate><creator>PAN, YUING EUGENE</creator><creator>GATELY, MAURICE KENT</creator><creator>HULMES, JEFFREY DAVID W</creator><creator>STERN, ALVIN SETH</creator><creator>CHIZZONITE, RICHARD ANTHONY</creator><creator>GUBLER, ULRICH ANDREAS</creator><creator>PODLANSKI, FRANK JOHN</creator><scope>EVB</scope></search><sort><creationdate>20070815</creationdate><title>MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR</title><author>PAN, YUING EUGENE ; GATELY, MAURICE KENT ; HULMES, JEFFREY DAVID W ; STERN, ALVIN SETH ; CHIZZONITE, RICHARD ANTHONY ; GUBLER, ULRICH ANDREAS ; PODLANSKI, FRANK JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE369383TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2007</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>PAN, YUING EUGENE</creatorcontrib><creatorcontrib>GATELY, MAURICE KENT</creatorcontrib><creatorcontrib>HULMES, JEFFREY DAVID W</creatorcontrib><creatorcontrib>STERN, ALVIN SETH</creatorcontrib><creatorcontrib>CHIZZONITE, RICHARD ANTHONY</creatorcontrib><creatorcontrib>GUBLER, ULRICH ANDREAS</creatorcontrib><creatorcontrib>PODLANSKI, FRANK JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAN, YUING EUGENE</au><au>GATELY, MAURICE KENT</au><au>HULMES, JEFFREY DAVID W</au><au>STERN, ALVIN SETH</au><au>CHIZZONITE, RICHARD ANTHONY</au><au>GUBLER, ULRICH ANDREAS</au><au>PODLANSKI, FRANK JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR</title><date>2007-08-15</date><risdate>2007</risdate><abstract>The present invention relates to a novel cytokine protein called Cytotoxic Lymphocyte Maturation Factor (CLMF) which is produced and synthesized by a human B lymphoblastoid cell line. CLMF synergistically induces in the presence of low concentrations of IL-2 the cytolytic activity of Lymphokine Activated Killer (LAK) cells. CLMF is also capable of stimulating T-cell growth. The present invention also relates to cloned genes coding for CLMF proteins and derivatives thereof, to recombinant vectors comprising a polynucleotide encoding a CLMF protein, to microorganisms transformed with the said recombinant vectors, to antibodies directed to the said proteins as well as to processes for the preparation of the said proteins, vectors and antibodies. Furthermore the present invention relates to methods for stimulating LAK cells, T-cells or Natural Killer Cells using the said CLMF protein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE369383TT1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title MONOKLONALE ANTIKÖRPER SPEZIFISCH FÜR DEN ZYTOTOXISCHEN LYMPHOZYTEN-REIFEFAKTOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A58%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAN,%20YUING%20EUGENE&rft.date=2007-08-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE369383TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true